Please login to the form below

Not currently logged in

FDA approves HIV antibodies screening test

The FDA has approved the Abbott Prism HIV O Plus assay as a screening tool to detect HIV in blood and organ donations

The US Food and Drug Administration (FDA) has approved the Abbott Prism HIV O Plus assay as a screening tool designed to detect the presence of antibodies to HIV type 1, groups M and O and HIV type 2.

The assay is the second donor screening test licensed for the detection of antibodies to HIV type 1, group O, and is one of five assays that run on the fully automated Abbott Prism System. During the past decade, fourth-generation assays have been developed that combine antigen and antibody detection in a single assay.

The test runs on Abbott Laboratories' Illinois-based system and will be used to screen for HIV in blood and organ donations.

HIV group M is the most common subgroup of the virus in the US and group O occurs primarily in West Africa.

21st September 2009


Featured jobs

Subscribe to our email news alerts


Add my company

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Australian Flu and the dilemma of naming diseases
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....